Consumption of anti-meticillin-resistant Staphylococcus aureus antibiotics in Swiss hospitals is associated with antibiotic stewardship measures.

Renggli, L.; Gasser, M.; Plüss-Suard, C.; Kronenberg, A. (2021). Consumption of anti-meticillin-resistant Staphylococcus aureus antibiotics in Swiss hospitals is associated with antibiotic stewardship measures. The journal of hospital infection, 117, pp. 165-171. Elsevier 10.1016/j.jhin.2021.08.019

[img]
Preview
Text
1-s2.0-S0195670121003042-main.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (716kB) | Preview

BACKGROUND

Consumption of antibiotics active against meticillin-resistant Staphylococcus aureus (MRSA) has been described in numerous European studies. However, the underlying predictors of consumption are still poorly understood.

AIM

To describe the consumption of anti-MRSA antibiotics (daptomycin, intravenous glycopeptides, linezolid) in Switzerland over time and to identify underlying predictor variables.

METHODS

A retrospective observational multi-centre study was conducted in 21 Swiss hospitals over a period of 11 years (2009-2019). Multiple linear regression models were built to identify regional and hospital-specific predictor variables affecting the consumption of anti-MRSA antibiotics.

FINDINGS

Consumption of anti-MRSA antibiotics increased between 2009 and 2019 from 12.7 to 24.5 defined daily doses per 1000 bed-days (+93%). In the first model presented, which includes data of the whole study period, the following variables were associated with higher anti-MRSA antibiotic consumption: number of MRSA cases (P < 0.01), year (P < 0.01), hospital type (tertiary care university hospitals vs others, P < 0.01), hospital department (intensive care unit vs others, P < 0.01) and linguistic region (French vs German and German vs Italian, P < 0.01). In a second model including data from a query on hospital policies in place in 2019, the presence of an antibiotic stewardship group (P < 0.01) and prescription restrictions (P < 0.01) were associated with consumption of anti-MRSA antibiotics.

CONCLUSION

Our study shows that both the presence of an antibiotic stewardship group and the implementation of prescription restrictions, i.e. factors that can be controlled by the hospital itself, were associated with a lower consumption of anti-MRSA antibiotics.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute for Infectious Diseases
04 Faculty of Medicine > Service Sector > Institute for Infectious Diseases > Research

Graduate School:

Graduate School for Health Sciences (GHS)

UniBE Contributor:

Renggli, Luzia Sonja, Gasser, Michael, Kronenberg, Andreas Oskar

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

1532-2939

Publisher:

Elsevier

Language:

English

Submitter:

Andreas Oskar Kronenberg

Date Deposited:

29 Oct 2021 09:55

Last Modified:

05 Dec 2022 15:53

Publisher DOI:

10.1016/j.jhin.2021.08.019

PubMed ID:

34428507

Uncontrolled Keywords:

Antibiotic stewardship Daptomycin Glycopeptides Linezolid Meticillin-resistant Staphylococcus aureus

BORIS DOI:

10.48350/160400

URI:

https://boris.unibe.ch/id/eprint/160400

Actions (login required)

Edit item Edit item
Provide Feedback